Patents Represented by Attorney Ted A. Chan
  • Patent number: 8329193
    Abstract: Methods for prolongation of climax time in a patient in need thereof are presented, as are methods for treating premature ejaculation by local administration of a Clostridial neurotoxin, such a botulinum neurotoxin, to the patient, are provided.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: December 11, 2012
    Assignee: Allergan, Inc.
    Inventors: Gustavo M. Gaxiola, Ivan E. Aguilar, Gilberto P. Paz
  • Patent number: 8324349
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: December 4, 2012
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Patent number: 8323666
    Abstract: A high potency botulinum toxin pharmaceutical composition comprising two excipients (such as albumin and sodium chloride) in a weight to weight ratio of between about 1 and about 100.
    Type: Grant
    Filed: August 1, 2005
    Date of Patent: December 4, 2012
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • Patent number: 8187612
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: May 29, 2012
    Assignee: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 8071578
    Abstract: The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: December 6, 2011
    Assignee: Allergan, Inc.
    Inventor: John Sefton